Back to
UBS Group AG
PYXSShowing 8 of 19 quarters
Position history for
UBS Group AG's holdings in PYXIS ONCOLOGY INC
Yes. Ubs holds 155,217 shares of PYXS (Pyxis Oncology), worth $467,203, as of its Q2 2026 13F filing. It reduced the position by 98,907 shares (-38.9%) from Q1 2026. Ubs has held PYXS since Q1 2023, across 14 quarterly 13F filings.
Current Value
$467,203
Current Shares
155,217
Total Value Change
+$364,069
Total Shares Change
+127,115
Quarter-by-Quarter History
Other major holders of PYXS: RA CAPITAL MANAGEMENT, L.P., RTW INVESTMENTS, LP, CITADEL ADVISORS LLC, Janus Henderson Group Ltd., BALYASNY ASSET MANAGEMENT L.P.